SE8701375D0 - Novel pyridyl- and pyrimidyl derivatives - Google Patents
Novel pyridyl- and pyrimidyl derivativesInfo
- Publication number
- SE8701375D0 SE8701375D0 SE8701375A SE8701375A SE8701375D0 SE 8701375 D0 SE8701375 D0 SE 8701375D0 SE 8701375 A SE8701375 A SE 8701375A SE 8701375 A SE8701375 A SE 8701375A SE 8701375 D0 SE8701375 D0 SE 8701375D0
- Authority
- SE
- Sweden
- Prior art keywords
- pct
- sec
- novel pyridyl
- date
- pyrimidyl derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8701375A SE8701375D0 (sv) | 1987-04-02 | 1987-04-02 | Novel pyridyl- and pyrimidyl derivatives |
IE86988A IE61165B1 (en) | 1987-04-02 | 1988-03-23 | Bisphenylalkylpiperazine derivatives, a method of their preparation and a pharmaceutical preparation |
NZ224005A NZ224005A (en) | 1987-04-02 | 1988-03-24 | Pyridyl- and pyrimidyl-substituted piperazine derivatives and pharmaceutical compositions |
PCT/SE1988/000144 WO1988007528A1 (en) | 1987-04-02 | 1988-03-25 | Bisphenylalkylpiperazine derivatives, a method of their preparation and a pharmaceutical preparation |
AU15796/88A AU611147B2 (en) | 1987-04-02 | 1988-03-25 | Bisphenylalkylpiperazine derivatives, a method of their preparation and a pharmaceutical preparation |
EP88903427A EP0308476B1 (en) | 1987-04-02 | 1988-03-25 | Bisphenylalkylpiperazine derivatives, a method of their preparation and a pharmaceutical preparation |
AT88903427T ATE85334T1 (de) | 1987-04-02 | 1988-03-25 | Bisphenylalkylpiperazin-derivate, verfahren zur herstellung und arzneimittelzubereitung. |
JP63503107A JPH0819104B2 (ja) | 1987-04-02 | 1988-03-25 | 新規なピリジルおよびピリミジル誘導体 |
DE8888903427T DE3878111T2 (de) | 1987-04-02 | 1988-03-25 | Bisphenylalkylpiperazin-derivate, verfahren zur herstellung und arzneimittelzubereitung. |
US07/282,130 US4937245A (en) | 1987-04-02 | 1988-03-25 | Bisphenylalkylpiperazine derivatives, a method of their preparation and a pharmaceutical preparation |
HU882510A HU201051B (en) | 1987-04-02 | 1988-03-25 | Bisphenylalkylpiperazine derivatives, a method of their preparation and a pharmaceutical preparation |
IL85932A IL85932A (en) | 1987-04-02 | 1988-03-30 | 1-pyridyl (or pyrimidyl)-4-diphenylbutyl piperazines, process for their preparation and pharmaceutical compositions containing them |
ES8800998A ES2006619A6 (es) | 1987-04-02 | 1988-03-30 | Un metodo para preparar derivados de piridil-y pirimidil-piperazinas. |
CA000563050A CA1321997C (en) | 1987-04-02 | 1988-03-31 | Pyridyl and pyrimidyl derivatives |
KR1019880003734A KR920003062B1 (ko) | 1987-04-02 | 1988-04-02 | 새로운 피리딜 및 피리미딜 유도체와 그의 제조방법 및 이들을 이용한 사람이외의 온혈동물의 스트레스 및 불안 치료 방법 |
FI885560A FI92320C (fi) | 1987-04-02 | 1988-11-30 | Menetelmä uusien terapeuttisesti käyttökelpoisten bisfenyylialkyylipiperatsiinijohdannaisten valmistamiseksi |
DK671588A DK161313C (da) | 1987-04-02 | 1988-12-01 | 4-(bis-fluorphenylbutyl)-1-(pyridyl- eller pyrimidinyl)-piperazin- eller -1,4-diazabicycloheptanforbindelser, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende disse samt anvendelse af forbindelserne |
NO885386A NO172640C (no) | 1987-04-02 | 1988-12-02 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinderivater |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8701375A SE8701375D0 (sv) | 1987-04-02 | 1987-04-02 | Novel pyridyl- and pyrimidyl derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SE8701375D0 true SE8701375D0 (sv) | 1987-04-02 |
Family
ID=20368077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8701375A SE8701375D0 (sv) | 1987-04-02 | 1987-04-02 | Novel pyridyl- and pyrimidyl derivatives |
Country Status (18)
Country | Link |
---|---|
US (1) | US4937245A (da) |
EP (1) | EP0308476B1 (da) |
JP (1) | JPH0819104B2 (da) |
KR (1) | KR920003062B1 (da) |
AT (1) | ATE85334T1 (da) |
AU (1) | AU611147B2 (da) |
CA (1) | CA1321997C (da) |
DE (1) | DE3878111T2 (da) |
DK (1) | DK161313C (da) |
ES (1) | ES2006619A6 (da) |
FI (1) | FI92320C (da) |
HU (1) | HU201051B (da) |
IE (1) | IE61165B1 (da) |
IL (1) | IL85932A (da) |
NO (1) | NO172640C (da) |
NZ (1) | NZ224005A (da) |
SE (1) | SE8701375D0 (da) |
WO (1) | WO1988007528A1 (da) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8701375D0 (sv) * | 1987-04-02 | 1987-04-02 | Leo Ab | Novel pyridyl- and pyrimidyl derivatives |
US5219855A (en) * | 1988-01-29 | 1993-06-15 | Mitsubishi Kasei Corporation | Anxiolytic drug |
JP2664238B2 (ja) * | 1989-03-01 | 1997-10-15 | 日清製粉株式会社 | ニコチン酸またはそのエステル誘導体 |
US4994460A (en) * | 1989-06-01 | 1991-02-19 | Bristol-Myers Squibb Co. | Agents for treatment of brain ischemia |
SE9201239D0 (sv) * | 1992-04-21 | 1992-04-21 | Kabi Pharmacia Ab | Agents for treating substance abuse disorders |
EP0580465A1 (fr) * | 1992-06-25 | 1994-01-26 | Sanofi | Nouvelle utilisation thérapeutique d'hétérocyclyl-pipérazines comme 5-HT3 agonistes et nouveaux dérivés |
JPH0665203A (ja) * | 1992-06-25 | 1994-03-08 | Elf Sanofi | ピペラジンのヘテロ環誘導体 |
SE9201956D0 (sv) * | 1992-06-25 | 1992-06-25 | Kabi Pharmacia Ab | Novel nicotinicacid esters |
SE9202265D0 (sv) * | 1992-07-31 | 1992-07-31 | Kabi Pharmacia Ab | Novel- pyridyl and pyrimidylpiperazine derivatives |
SK285198B6 (sk) | 1997-10-27 | 2006-08-03 | Neurosearch A/S | Homopiperazínový derivát, farmaceutická kompozícia obsahujúca tento derivát a jeho použitie |
US6632823B1 (en) * | 1997-12-22 | 2003-10-14 | Merck & Co., Inc. | Substituted pyridine compounds useful as modulators of acetylcholine receptors |
CA2369103A1 (en) | 1999-04-09 | 2000-10-19 | Meiji Seika Kaisha, Ltd. | Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2958694A (en) * | 1959-06-22 | 1960-11-01 | Janssen Paul Adriaan Jan | 1-(aroylalkyl)-4-(2'-pyridyl) piperazines |
US2985657A (en) * | 1959-10-12 | 1961-05-23 | Paul A J Janssen | 1-(aroylalkyl)-4-heterocyclylpiperazines |
US2979508A (en) * | 1959-10-12 | 1961-04-11 | Paul A J Janssen | Heterocyclic derivatives of 1-phenyl-omega-(piperazine) alkanols |
JPS6081167A (ja) * | 1983-10-11 | 1985-05-09 | Sumitomo Chem Co Ltd | フエニルアセトン誘導体およびその製造法 |
US4605655A (en) * | 1984-03-06 | 1986-08-12 | Bristol-Myers Company | Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives |
JPS6175A (ja) * | 1984-03-06 | 1986-01-06 | ブリストル−マイア−ズ コムパニ− | 神経弛緩剤、1‐フルオロフェニルブチル‐4‐(5‐ハロ‐2‐ピリミジニル)ピペラジン誘導体 |
GB8603120D0 (en) * | 1986-02-07 | 1986-03-12 | Pfizer Ltd | Anti-dysrhythmia agents |
JPS63146872A (ja) * | 1986-07-08 | 1988-06-18 | Yoshitomi Pharmaceut Ind Ltd | ピリミジニルピペラジン化合物 |
US4766215A (en) * | 1987-02-27 | 1988-08-23 | American Home Products Corporation | Histamine H1 -receptor antagonists |
SE8701375D0 (sv) * | 1987-04-02 | 1987-04-02 | Leo Ab | Novel pyridyl- and pyrimidyl derivatives |
-
1987
- 1987-04-02 SE SE8701375A patent/SE8701375D0/xx unknown
-
1988
- 1988-03-23 IE IE86988A patent/IE61165B1/en not_active IP Right Cessation
- 1988-03-24 NZ NZ224005A patent/NZ224005A/en unknown
- 1988-03-25 EP EP88903427A patent/EP0308476B1/en not_active Expired - Lifetime
- 1988-03-25 AU AU15796/88A patent/AU611147B2/en not_active Ceased
- 1988-03-25 WO PCT/SE1988/000144 patent/WO1988007528A1/en active IP Right Grant
- 1988-03-25 HU HU882510A patent/HU201051B/hu not_active IP Right Cessation
- 1988-03-25 JP JP63503107A patent/JPH0819104B2/ja not_active Expired - Fee Related
- 1988-03-25 US US07/282,130 patent/US4937245A/en not_active Expired - Lifetime
- 1988-03-25 DE DE8888903427T patent/DE3878111T2/de not_active Expired - Fee Related
- 1988-03-25 AT AT88903427T patent/ATE85334T1/de not_active IP Right Cessation
- 1988-03-30 IL IL85932A patent/IL85932A/xx not_active IP Right Cessation
- 1988-03-30 ES ES8800998A patent/ES2006619A6/es not_active Expired
- 1988-03-31 CA CA000563050A patent/CA1321997C/en not_active Expired - Fee Related
- 1988-04-02 KR KR1019880003734A patent/KR920003062B1/ko not_active IP Right Cessation
- 1988-11-30 FI FI885560A patent/FI92320C/fi not_active IP Right Cessation
- 1988-12-01 DK DK671588A patent/DK161313C/da not_active IP Right Cessation
- 1988-12-02 NO NO885386A patent/NO172640C/no unknown
Also Published As
Publication number | Publication date |
---|---|
FI92320B (fi) | 1994-07-15 |
NO172640C (no) | 1993-08-18 |
NZ224005A (en) | 1991-03-26 |
NO885386D0 (no) | 1988-12-02 |
KR880012586A (ko) | 1988-11-28 |
FI885560A0 (fi) | 1988-11-30 |
FI92320C (fi) | 1994-10-25 |
CA1321997C (en) | 1993-09-07 |
IL85932A0 (en) | 1988-09-30 |
DK671588A (da) | 1988-12-01 |
WO1988007528A1 (en) | 1988-10-06 |
HU201051B (en) | 1990-09-28 |
ES2006619A6 (es) | 1989-05-01 |
FI885560A (fi) | 1988-11-30 |
IE880869L (en) | 1988-10-02 |
JPH0819104B2 (ja) | 1996-02-28 |
US4937245A (en) | 1990-06-26 |
NO885386L (no) | 1988-12-02 |
EP0308476A1 (en) | 1989-03-29 |
DE3878111T2 (de) | 1993-07-01 |
IL85932A (en) | 1993-05-13 |
JPH01502832A (ja) | 1989-09-28 |
KR920003062B1 (ko) | 1992-04-13 |
DK161313B (da) | 1991-06-24 |
AU611147B2 (en) | 1991-06-06 |
IE61165B1 (en) | 1994-10-05 |
HUT50325A (en) | 1990-01-29 |
DE3878111D1 (de) | 1993-03-18 |
DK161313C (da) | 1991-12-30 |
AU1579688A (en) | 1988-11-02 |
NO172640B (no) | 1993-05-10 |
ATE85334T1 (de) | 1993-02-15 |
EP0308476B1 (en) | 1993-02-03 |
DK671588D0 (da) | 1988-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ1794A1 (fr) | Nouvelle formule pharmaceutique. | |
IL116122A0 (en) | Intermediates to heterocyclic-cyclic amine derivatives | |
NO933200L (no) | Substituerte cykloheksanderivater, fremgangsmåte til fremstilling derav og anvendelsen av forbindelsene til behandling av sykdommer | |
ATE192152T1 (de) | Piperidinderivate mit paf antagonistischer wirkung | |
SE8701375D0 (sv) | Novel pyridyl- and pyrimidyl derivatives | |
ATE123024T1 (de) | 4-aminopyridinderivate. | |
MD1560G2 (ro) | Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri | |
FR2700165B1 (fr) | Dérivés de pyrrolidine, leur préparation et les médicaments les contenant. | |
DK0401093T3 (da) | Hidtil ukendte pyrrolidonderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende disse | |
ZA88639B (en) | Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,medicaments containing same and the use thereof,and also some intermediates formed in the preparation of the compounds mentioned | |
PT889044E (pt) | Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central | |
DK0729469T3 (da) | Imidazo[1,5-a]quinoliner til behandling af angst og søvnforstyrrelser | |
ES2119454T3 (es) | Derivados de pirrolidina para el tratamiento de los desordenes relacionados con la csk y la gastrina. | |
RO88666A (ro) | Procedeu de obtinere a unor derivati de 6 &-metilprednisolon |